Summary & Overview
Chemotherapy without Acute Leukemia as Secondary Diagnosis without CC/MCC: Inpatient Reimbursement Overview
DRG 848 encompasses inpatient admissions for chemotherapy when acute leukemia is not present as a secondary diagnosis and there are no Complication or Comorbidity or Major Complication or Comorbidity present. This classification defines the expected resource use and sets the standardized Medicare payment rate for such uncomplicated chemotherapy hospital stays.
DRG 848 Overview
DRG 848 covers inpatient hospital stays where chemotherapy is the primary reason for admission and acute leukemia is not listed as a secondary diagnosis, without any Complication or Comorbidity or Major Complication or Comorbidity. This Diagnosis-Related Group groups patients with relatively straightforward chemotherapy needs and lower resource use compared with cases that have major complications. It matters for Medicare payment because it establishes the prospective payment rate for these admissions under the inpatient prospective payment system. Accurate assignment affects hospital reimbursement and billing categorization.